Claus Kim Høgdall

Prof. Dr. Claus Kim Høgdall

orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2013 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SBStig E Bojesen
Stig E Bojesen
KPKaren A Pooley
Karen A Pooley
SJSharon E Johnatty
Sharon E Johnatty
JBJonathan Beesley
Jonathan Beesley
KMKyriaki Michailidou
Kyriaki Michailidou
ADAlison M Dunning
Alison M Dunning
Stig Bojesen, Georgia Chenevix-Trench, Alison Dunning and colleagues report common variants at the TERT-CLPTM1L locus associated with mean telomere length measured in whole blood. They also identify associations at this locus to breast or ovarian cancer susceptibility and report functional studies in breast and ovarian cancer tissue and cell lines. TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOGs, we analyzed ∼480 SNPs at the TERT locus in breast (n = 103,991), ovarian (n = 39,774) and BRCA1 mutation carrier (n = 11,705) cancer cases and controls. Leukocyte telomere measurements were also available for 53,724 participants. Most associations cluster into three independent peaks. The minor allele at the peak 1 SNP rs2736108 associates with longer telomeres (P = 5.8 × 10−7), lower risks for estrogen receptor (ER)-negative (P = 1.0 × 10−8) and BRCA1 mutation carrier (P = 1.1 × 10−5) breast cancers and altered promoter assay signal. The minor allele at the peak 2 SNP rs7705526 associates with longer telomeres (P = 2.3 × 10−14), higher risk of low-malignant-potential ovarian cancer (P = 1.3 × 10−15) and greater promoter activity. The minor alleles at the peak 3 SNPs rs10069690 and rs2242652 increase ER-negative (P = 1.2 × 10−12) and BRCA1 mutation carrier (P = 1.6 × 10−14) breast and invasive ovarian (P = 1.3 × 10−11) cancer risks but not via altered telomere length. The cancer risk alleles of rs2242652 and rs10069690, respectively, increase silencing and generate a truncated TERT splice variant.

27 March 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CPCatherine M Phelan
Catherine M Phelan
KKKaroline B Kuchenbaecker
Karoline B Kuchenbaecker
JTJonathan P Tyrer
Jonathan P Tyrer
SKSiddhartha P. Kar
Siddhartha P. Kar
KLKate Lawrenson
Kate Lawrenson
PPPaul Pharoah
Paul Pharoah
Paul Pharoah and colleagues report the results of a large genome-wide association study of ovarian cancer. They identify new susceptibility loci for different epithelial ovarian cancer histotypes and use integrated analyses of genes and regulatory features at each locus to predict candidate susceptibility genes, including OBFC1. To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, 4q32.3, 8q21.11, 10q24.33, 18q11.2 and 22q12.1), two for mucinous EOC (3q22.3 and 9q31.1) and one for endometrioid EOC (5q12.3). We then performed meta-analysis on the results for high-grade serous ovarian cancer with the results from analysis of 31,448 BRCA1 and BRCA2 mutation carriers, including 3,887 mutation carriers with EOC. This identified three additional susceptibility loci at 2q13, 8q24.1 and 12q24.31. Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC.

1 August 2013 in The Lancet Oncology
Verified
Journal Article
Closed access
WSWeiva Sieh
Weiva Sieh
MKMartin Köbel
Martin Köbel
TLTeri A Longacre
Teri A Longacre
DBDavid D Bowtell
David D Bowtell
ADAnna Defazio
Anna Defazio
SRSusan Ramus
Susan Ramus

27 March 2013 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ASAustralian Cancer Study
Australian Cancer Study
PPPaul D P Pharoah
Paul D P Pharoah
AGAustralian Ovarian Cancer Study Group
Australian Ovarian Cancer Study Group
YTYa-Yu Tsai
Ya-Yu Tsai
SRSusan Ramus
Susan Ramus
TSThomas A Sellers
Thomas A Sellers
Paul Pharoah, Joellen Schildkraut, Thomas Sellers and colleagues report a meta-analysis of genome-wide association studies for epithelial ovarian cancer and genotyping using the iCOGS array in 18,174 cases and 26,134 controls from 43 studies from the Ovarian Cancer Association Consortium. They identify three new ovarian cancer susceptibility loci, including one specific to the serous subtype, and their integrated molecular analysis of genes and regulatory regions at these loci suggests disease mechanisms. Genome-wide association studies (GWAS) have identified four susceptibility loci for epithelial ovarian cancer (EOC), with another two suggestive loci reaching near genome-wide significance. We pooled data from a GWAS conducted in North America with another GWAS from the UK. We selected the top 24,551 SNPs for inclusion on the iCOGS custom genotyping array. We performed follow-up genotyping in 18,174 individuals with EOC (cases) and 26,134 controls from 43 studies from the Ovarian Cancer Association Consortium. We validated the two loci at 3q25 and 17q21 that were previously found to have associations close to genome-wide significance and identified three loci newly associated with risk: two loci associated with all EOC subtypes at 8q21 (rs11782652, P = 5.5 × 10−9) and 10p12 (rs1243180, P = 1.8 × 10−8) and another locus specific to the serous subtype at 17q12 (rs757210, P = 8.1 × 10−10). An integrated molecular analysis of genes and regulatory regions at these loci provided evidence for functional mechanisms underlying susceptibility and implicated CHMP4C in the pathogenesis of ovarian cancer.

14 October 2009 in JAMA
Verified
Journal Article
Open access
PDF file
Christian S. MeyhoffChristian S. Meyhoff
Christian S. Meyhoff
JWJørn Wetterslev
Jørn Wetterslev
LJLars N. Jorgensen
Lars N. Jorgensen
SHSteen W. Henneberg
Steen W. Henneberg
CHClaus Kim Høgdall
Claus Kim Høgdall
FGfor the PROXI Trial Group
for the PROXI Trial Group
Surgical site infection is a common and serious complication following abdominal surgery.1 To prevent surgical site infection, it is essential to optimize perioperative conditions in the first hours following bacterial contamination.2 Tissue oxygen tension is often low in wounds and colorectal anastomoses, and this may reduce tissue healing via oxidative killing by neutrophils and also reduce induction of collagen formation, neovascularization, and epithelialization.3-7 Perioperative arterial and wound oxygen tension can be increased by a higher inspiratory oxygen fraction.7

19 September 2010 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TCThe Wellcome Trust Case-Control Consortium
The Wellcome Trust Case-Control Consortium
EGEllen L Goode
Ellen L Goode
TCThe Australian Cancer Study (Ovarian Cancer)
The Australian Cancer Study (Ovarian Cancer)
TGThe Australian Ovarian Cancer Study Group
The Australian Ovarian Cancer Study Group
T(the Ovarian Cancer Association Consortium (OCAC)
the Ovarian Cancer Association Consortium (OCAC)
PWPenelope M Webb
Penelope M Webb